Davis Jerel - Jun 3, 2024 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
Director, 10%+ Owner
Signature
/s/ Venkat Ramanan, Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
7/2/2024, 04:45 PM
Previous filing
Oct 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSBX Stock Option (Right to Buy) Award $0 +12.8K $0.00 12.8K Jun 3, 2024 Common Stock 12.8K $2.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 3, 2025 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.